Inspired by oxygen‐carrying ability of RBCs, a series of oxygen‐generator materials (such as hemoglobin, perfluorocarbons, and catalase‐like nanozymes) have been developed to alleviate tumor hypoxia and elevate therapeutic outcomes.[59, 60] Li et al. The gene discussed is CAT; the disease is neoplasm.